Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Simple item page
dc.contributor.authorBrissot, Éolia
dc.contributor.authorAlsuliman, Tamim
dc.contributor.authorBeauvais, David
dc.contributor.authorBonnin, Agnès
dc.contributor.authorMéar, Jean Baptiste
dc.contributor.authorSouchet, Laëtitia
dc.contributor.authorVillate, Alban
dc.contributor.authorYakoub-Agha, Ibrahim
dc.contributor.authorBazarbachi, Ali Abdul Hamid
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:57:10Z
dc.date.available2025-01-24T11:57:10Z
dc.date.issued2020
dc.description.abstractThe Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here, we report our recommendations regarding the prophylaxis of cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV) and hepatitis B virus infection after allogeneic hematopoietic cell transplantation in adult patients. © 2019 Société Française du Cancer
dc.identifier.doihttps://doi.org/10.1016/j.bulcan.2019.09.002
dc.identifier.urihttp://hdl.handle.net/10938/31283
dc.language.isoen
dc.publisherJohn Libbey Eurotext
dc.sourceScopus
dc.subjectAllogeneic stem cell transplantation
dc.subjectCmv
dc.subjectHbv
dc.subjectHsv
dc.subjectProphylaxis
dc.subjectVzv
dc.subjectAcetates
dc.subjectAdult
dc.subjectAllografts
dc.subjectAntiviral agents
dc.subjectCytomegalovirus infections
dc.subjectHematopoietic stem cell transplantation
dc.subjectHepatitis b
dc.subjectHerpes simplex
dc.subjectHerpes zoster
dc.subjectHumans
dc.subjectQuinazolines
dc.subjectTransplantation conditioning
dc.subjectAntivirus agent
dc.subjectAcetic acid
dc.subjectLetermovir
dc.subjectQuinazoline derivative
dc.subjectAllogeneic hematopoietic stem cell transplantation
dc.subjectAntiviral therapy
dc.subjectCytomegalovirus
dc.subjectCytomegalovirus infection
dc.subjectHepatitis b virus
dc.subjectHerpes simplex virus
dc.subjectHuman
dc.subjectMedical society
dc.subjectNonhuman
dc.subjectPractice guideline
dc.subjectReview
dc.subjectVaricella zoster virus
dc.subjectAdverse event
dc.subjectAllograft
dc.subjectConsensus development
dc.titleAntiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2020-3663.pdf
Size:
354.4 KB
Format:
Adobe Portable Document Format
Download

Collections

Internal Medicine